{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:20:39Z","timestamp":1791411639000,"version":"4.3.3"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.brachy.2018.07.002","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T11:09:47Z","timestamp":1533294587000},"page":"981-989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review"],"prefix":"10.1016","volume":"17","author":[{"given":"Bao Han A.","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"Rayess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Jennelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Y.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin A.","family":"Astrahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse L.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2018.07.002_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0360-3016(97)00118-1","article-title":"Conformal episcleral plaque therapy","volume":"39","author":"Astrahan","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib3","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3928\/23258160-20150909-12","article-title":"Use of the toric surgical marker to aid in intraoperative plaque placement for the USC eye physics plaques to treat uveal melanoma: a new surgical technique","volume":"46","author":"Berry","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.brachy.2018.07.002_bib4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/jamaophthalmol.2013.4422","article-title":"Outcomes of choroidal melanomas treated with eye physics: a 20-year review","volume":"131","author":"Berry","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.brachy.2018.07.002_bib5","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.prro.2017.01.002","article-title":"Early outcomes of uveal melanoma treated with intraoperative ultrasound guided brachytherapy using custom built plaques","volume":"7","author":"Tann","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2018.07.002_bib6","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/sj.eye.6702911","article-title":"Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation","volume":"22","author":"Krohn","year":"2008","journal-title":"Eye Lond"},{"key":"10.1016\/j.brachy.2018.07.002_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2008.10.013","article-title":"Collaborative ocular melanoma study group. I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the collaborative ocular melanoma study: COMS report no. 30","volume":"116","author":"Boldt","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2018.07.002_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.oret.2017.01.014","article-title":"Treatment outcomes of focal laser consolidation during chemoreduction for group b retinoblastoma - sciencedirect","volume":"1","author":"Kim","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.brachy.2018.07.002_bib9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1118\/1.596585","article-title":"Optimization of 125I ophthalmic plaque brachytherapy","volume":"17","author":"Astrahan","year":"1990","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0360-3016(90)90077-W","article-title":"An interactive treatment planning system for ophthalmic plaque radiotherapy","volume":"18","author":"Astrahan","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib11","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2018.07.002_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2018.07.002_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ophtha.2015.09.014","article-title":"Local recurrence significantly increases the risk of metastatic uveal melanoma","volume":"123","author":"The Ophthalmic Oncology Task Force","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2018.07.002_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajo.2017.05.019","article-title":"Pattern of local recurrence after I-125 episcleral brachytherapy for uveal melanoma in a Spanish referral ocular oncology unit","volume":"180","author":"Sanchez-Tabernero","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2018.07.002_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000455872","article-title":"Iodine-125 brachytherapy for uveal melanoma: a systematic review of radiation dose","volume":"3","author":"Echegaray","year":"2017","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.brachy.2018.07.002_bib16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ophtha.2011.08.046","article-title":"Multi-year follow-up of fine-needle aspiration biopsy in choroidal melanoma","volume":"119","author":"McCannel","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2018.07.002_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2014.01.026","article-title":"Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes","volume":"89","author":"Perez","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib18","first-page":"609","article-title":"Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma","volume":"1999","author":"G\u00fcnd\u00fcz","year":"1960","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2018.07.002_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jamaophthalmol.2016.0104","article-title":"Vision loss following episcleral brachytherapy for uveal melanoma: development of a vision prognostication tool","volume":"134","author":"Aziz","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.brachy.2018.07.002_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0360-3016(93)90277-3","article-title":"High intensity 125-iodine (125I) plaque treatment of uveal melanoma","volume":"26","author":"Quivey","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/eye.2009.43","article-title":"Ocular complications following I-125 brachytherapy for choroidal melanoma","volume":"23","author":"Wen","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.brachy.2018.07.002_bib22","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1167\/iovs.04-0066","article-title":"Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques","volume":"45","author":"Puusaari","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.brachy.2018.07.002_bib23","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0360-3016(01)02723-7","article-title":"Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects","volume":"52","author":"Jones","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1442-9071.2005.01067.x","article-title":"New Zealand experience of I125 brachytherapy for choroidal melanoma","volume":"33","author":"Stack","year":"2005","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.brachy.2018.07.002_bib25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0360-3016(03)00006-3","article-title":"The American brachytherapy society recommendations for brachytherapy of uveal melanomas","volume":"56","author":"Nag","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib26","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0161-6420(99)90455-4","article-title":"Risk factors for radiation maculopathy and papillopathy after intraocular irradiation","volume":"106","author":"Gragoudas","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2018.07.002_bib27","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ajo.2009.11.006","article-title":"Risk factors for radiation maculopathy after ophthalmic plaque radiation for choroidal melanoma","volume":"149","author":"Finger","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2018.07.002_bib28","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/archophthalmol.2011.161","article-title":"Subfoveal choroidal melanoma: pretreatment characteristics and response to plaque radiation therapy","volume":"129","author":"Newman","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2018.07.002_bib29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF00195358","article-title":"Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru\/106Rh plaques","volume":"232","author":"Lommatzsch","year":"1994","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.brachy.2018.07.002_bib30","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Radiation dose-volume effects of optic nerves and chiasm","volume":"76","author":"Mayo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib31","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2010.02.051","article-title":"Risk factors for cataract after palladium-103 ophthalmic plaque radiation therapy","volume":"80","author":"Finger","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib32","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/bjo.84.9.1068","article-title":"Tumour location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapy","volume":"84","author":"Finger","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2018.07.002_bib33","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.ijrobp.2012.01.084","article-title":"Dosimetric benefit of a new ophthalmic radiation plaque","volume":"84","author":"Marwaha","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5114\/jcb.2013.34450","article-title":"The retina dose-area histogram: a metric for quantitatively comparing rival eye plaque treatment options","volume":"5","author":"Astrahan","year":"2013","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2018.07.002_bib35","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ijrobp.2004.09.062","article-title":"Improved treatment planning for COMS eye plaques","volume":"61","author":"Astrahan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib36","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib37","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0360-3016(01)01768-0","article-title":"Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy","volume":"51","author":"Knutsen","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1120\/jacmp.v16i6.5659","article-title":"Episcleral eye plaque dosimetry comparison for the eye physics EP917 using plaque simulator and Monte Carlo simulation","volume":"16","author":"Zimmermann","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib39","first-page":"1054","article-title":"Implications of TG-43 for dose prescription and calculation for I-125 eye plaques","volume":"23","author":"Kline","year":"1996","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2018.07.002_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118301089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118301089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:14:35Z","timestamp":1761531275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472118301089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1538472118301089"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2018.07.002","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2018.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}